Bacillus coagulans as a potent intervention for treating irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials
AbdelQadir YH, Nabhan AI, Althawadi Y, Belal MM, et al.
Published in Human Nutrition & Metabolism
Abstract
Systematic review and meta-analysis of randomized controlled trials of Bacillus coagulans in IBS.
Key Findings
Pooled RCT data showed B. coagulans improved global IBS symptom scores and abdominal pain compared with placebo.
Conclusions
B. coagulans is a promising probiotic intervention for IBS, though trials are few and small.
Limitations
Small number of trials, heterogeneity in strains and doses, risk of industry bias.
Supplements Studied
Pooled RCT data showed B. coagulans improved global IBS symptom scores and abdominal pain compared with placebo.
Outcomes Measured
Pooled RCT data showed B. coagulans improved global IBS symptom scores and abdominal pain compared with placebo.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.